CXCL10/CXCR3 signaling in glia cells differentially affects NMDA-induced cell death in CA and DG neurons of the mouse hippocampus

Hippocampus

Volumn 21, Issue 2, 2011, Pages 220-232

  Van Weering, Hilmar R J ^a   Boddeke, Hendrikus W G M ^a   Vinet, Jonathan ^a   Brouwer, Nieske ^a   De Haas, Alexander H ^a   Van Rooijen, Nico ^b   Thomsen, Allan R ^c   Biber, Knut P H ^a,d  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Astrocyte; Chemokines; Excitotoxicity; Liposomic clodronate; Microglia

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; CLODRONIC ACID; GAMMA INTERFERON INDUCIBLE PROTEIN 10; LIPOSOME; N METHYL DEXTRO ASPARTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL DEATH; CELL DIFFERENTIATION; CELL INTERACTION; CENTRAL NERVOUS SYSTEM DISEASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; EXCITOTOXICITY; GLIA CELL; HIPPOCAMPUS; MICROGLIA; MOUSE; NERVE CELL NECROSIS; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ASTROCYTES; CA1 REGION, HIPPOCAMPAL; CA3 REGION, HIPPOCAMPAL; CELL DEATH; CHEMOKINE CXCL10; DENTATE GYRUS; HIPPOCAMPUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; N-METHYLASPARTATE; NEUROGLIA; NEURONS; RECEPTORS, CXCR3; SIGNAL TRANSDUCTION;

EID: 79251536509     PISSN: 10509631     EISSN: 10981063     Source Type: Journal    
DOI: 10.1002/hipo.20742     Document Type: Article

References (72)

1. Acarin L, Gonzalez B, Castellano B, Castro AJ. 1996. Microglial response to N-methyl-D-aspartate-mediated excitotoxicity in the immature rat brain. J Comp Neurol 367: 361-374.
2. Aloisi F. 2001. Immune function of microglia. Glia 36: 165-179.
3. Arundine M, Tymianski M. 2003. Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity. Cell Calcium 34: 325-337.
4. Balashov KE, Rottman JB, Weiner HL, Hancock WW. 1999. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci USA 96: 6873-6878.
5. Barone FC, Feuerstein GZ. 1999. Inflammatory mediators and stroke: New opportunities for novel therapeutics. J Cereb Blood Flow Metab 19: 819-834.
6. Bhowmick S, Duseja R, Das S, Appaiahgiri MB, Vrati S, Basu A. 2007. Induction of IP-10 (CXCL10) in astrocytes following Japanese encephalitis. Neurosci Lett 414: 45-50.
7. Biber K, Dijkstra I, Trebst C, De Groot CJ, Ransohoff RM, Boddeke HW. 2002. Functional expression of CXCR3 in cultured mouse and human astrocytes and microglia. Neuroscience 112: 487-497.
8. Biber K, Klotz KN, Berger M, Gebicke-Harter PJ, van CD. 1997. Adenosine A1 receptor-mediated activation of phospholipase C in cultured astrocytes depends on the level of receptor expression. J Neurosci 17: 4956-4964.
9. Biber K, Sauter A, Brouwer N, Copray SC, Boddeke HW. 2001. Ischemia-induced neuronal expression of the microglia attracting chemokine Secondary Lymphoid-tissue Chemokine (SLC). Glia 34: 121-133.
10. Boztug K, Carson MJ, Pham-Mitchell N, Asensio VC, Demartino J, Campbell IL. 2002. Leukocyte infiltration, but not neurodegeneration, in the CNS of transgenic mice with astrocyte production of the CXC chemokine ligand 10. J Immunol 169: 1505-1515.
11. Campuzano O, Castillo-Ruiz MM, Acarin L, Castellano B, Gonzalez B. 2008. Distinct pattern of microglial response, cyclooxygenase-2, and inducible nitric oxide synthase expression in the aged rat brain after excitotoxic damage. J Neurosci Res 86: 3170-3183.
12. Carter SL, Muller M, Manders PM, Campbell IL. 2007. Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN-gamma but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro. Glia 55: 1728-1739.
13. Cartier L, Hartley O, Dubois-Dauphin M, Krause KH. 2005. Chemokine receptors in the central nervous system: Role in brain inflammation and neurodegenerative diseases. Brain Res Brain Res Rev 48: 16-42.
14. Cho J, Nelson TE, Bajova H, Gruol DL. 2009. Chronic CXCL10 alters neuronal properties in rat hippocampal culture. J Neuroimmunol 207: 92-100.
15. Choi DW. 1988. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1: 623-634.
16. Choi DW, Rothman SM. 1990. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci 13: 171-182.
17. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159.
18. Cinque P, Bestetti A, Marenzi R, Sala S, Gisslen M, Hagberg L, Price RW. 2005. Cerebrospinal fluid interferon-gamma-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection J Neuroimmunol 168: 154-163.
19. Copray JC, Brouwer N. 1994. Selective expression of neurotrophin-3 messenger RNA in muscle spindles of the rat. Neuroscience 63: 1125-1135.
20. Coughlan CM, McManus CM, Sharron M, Gao Z, Murphy D, Jaffer S, Choe W, Chen W, Hesselgesser J, Gaylord H, Kalyuzhny A, Lee VM, Wolf B, Doms RW, Kolson DL. 2000. Expression of multiple functional chemokine receptors and monocyte chemoattractant protein-1 in human neurons. Neuroscience 97: 591-600.
21. Croitoru-Lamoury J, Guillemin GJ, Boussin FD, Mognetti B, Gigout LI, Cheret A, Vaslin B, Le GR, Brew BJ, Dormont D. 2003. Expression of chemokines and their receptors in human and simian astrocytes: Evidence for a central role of TNF alpha and IFN gamma in CXCR4 and CCR5 modulation. Glia 41: 354-370.
22. De Haas AH, Boddeke HW, Biber K. 2008. Region-specific expression of immunoregulatory proteins on microglia in the healthy CNS. Glia 56: 888-894.
23. De Haas AH, Van Weering HR, De Jong EK, Boddeke HW, Biber KP. 2007. Neuronal chemokines: Versatile messengers in central nervous system cell interaction. Mol Neurobiol 36: 137-151.
24. Dehghani F, Hischebeth GT, Wirjatijasa F, Kohl A, Korf HW, Hailer NP. 2003. The immunosuppressant mycophenolate mofetil attenuates neuronal damage after excitotoxic injury in hippocampal slice cultures. Eur J Neurosci 18: 1061-1072.
25. Dijkstra IM, Hulshof S, van der Valk P, Boddeke HW, Biber K. 2004. Cutting edge: Activity of human adult microglia in response to CC chemokine ligand 21. J Immunol 172: 2744-2747.
26. Fife BT, Kennedy KJ, Paniagua MC, Lukacs NW, Kunkel SL, Luster AD, Karpus WJ. 2001. CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis. J Immunol 166: 7617-7624.
27. Flynn G, Maru S, Loughlin J, Romero IA, Male D. 2003. Regulation of chemokine receptor expression in human microglia and astrocytes. J Neuroimmunol 136: 84-93.
28. Galimberti D, Schoonenboom N, Scheltens P, Fenoglio C, Bouwman F, Venturelli E, Guidi I, Blankenstein MA, Bresolin N, Scarpini E. 2006. Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease. Arch Neurol 63: 538-543.
29. Glaser J, Gonzalez R, Sadr E, Keirstead HS. 2006. Neutralization of the chemokine CXCL10 reduces apoptosis and increases axon sprouting after spinal cord injury. J Neurosci Res 84: 724-734.
30. Goldberg SH, Van der Meer P, Hesselgesser J, Jaffer S, Kolson DL, Albright AV, Gonzalez-Scarano F, Lavi E. 2001. CXCR3 expression in human central nervous system diseases. Neuropathol Appl Neurobiol 27: 127-138.
31. Hailer NP. 2008. Immunosuppression after traumatic or ischemic CNS damage: it is neuroprotective and illuminates the role of microglial cells. Prog Neurobiol 84: 211-233.
32. Hailer NP, Vogt C, Korf HW, Dehghani F. 2005. Interleukin-1beta exacerbates and interleukin-1 receptor antagonist attenuates neuronal injury and microglial activation after excitotoxic damage in organotypic hippocampal slice cultures. Eur J Neurosci 21: 2347-2360.
33. Heppner FL, Skutella T, Hailer NP, Haas D, Nitsch R. 1998. Activated microglial cells migrate towards sites of excitotoxic neuronal injury inside organotypic hippocampal slice cultures. Eur J Neurosci 10: 3284-3290.
34. Hua LL, Lee SC. 2000. Distinct patterns of stimulus-inducible chemokine mRNA accumulation in human fetal astrocytes and microglia. Glia 30: 74-81.
35. Imai F, Suzuki H, Oda J, Ninomiya T, Ono K, Sano H, Sawada M. 2007. Neuroprotective effect of exogenous microglia in global brain ischemia. J Cereb Blood Flow Metab 27: 488-500.
36. Kitamura Y, Takata K, Inden M, Tsuchiya D, Yanagisawa D, Nakata J, Taniguchi T. 2004. Intracerebroventricular injection of microglia protects against focal brain ischemia. J Pharmacol Sci 94: 203-206.
37. Klein RS, Izikson L, Means T, Gibson HD, Lin E, Sobel RA, Weiner HL, Luster AD. 2004. IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis. J Immunol 172: 550-559.
38. Kohl A, Dehghani F, Korf HW, Hailer NP. 2003. The bisphosphonate clodronate depletes microglial cells in excitotoxically injured organotypic hippocampal slice cultures. Exp Neurol 181: 1-11.
39. Kurpius D, Nolley EP, Dailey ME. 2007. Purines induce directed migration and rapid homing of microglia to injured pyramidal neurons in developing hippocampus. Glia 55: 873-884.
40. Lalancette-Hebert M, Gowing G, Simard A, Weng YC, Kriz J. 2007. Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J Neurosci 27: 2596-2605.
41. Liu L, Callahan MK, Huang D, Ransohoff RM. 2005. Chemokine receptor CXCR3: an unexpected enigma. Curr Top Dev Biol 68: 149-181.
42. Li H, Gang Z, Yuling H, Luokun X, Jie X, Hao L, Li W, Chunsong H, Junyan L, Mingshen J, Youxin J, Feili G, Boquan J, Jinquan T. 2006. Different neurotropic pathogens elicit neurotoxic CCR9- or neurosupportive CXCR3-expressing microglia. J Immunol 177: 3644-3656.
43. -/- mice with experimental autoimmune encephalomyelitis. J Immunol 176: 4399-4409.
44. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR, the 2(-Delta Delta C(T)) method. Methods 25: 402-408.
45. Loetscher M, Loetscher P, Brass N, Meese E, Moser B. 1998. Lymphocyte-specific chemokine receptor CXCR3: Regulation, chemokine binding and gene localization. Eur J Immunol 28: 3696-3705.
46. Marin-Teva JL, Dusart I, Colin C, Gervais A, van Rooijen N, Mallat M. 2004. Microglia promote the death of developing Purkinje cells. Neuron 41: 535-547.
47. Markovic DS, Glass R, Synowitz M, Van Rooijen N, Kettenmann H. 2005. Microglia stimulate the invasiveness of glioma cells by increasing the activity of metalloprotease-2. J Neuropathol Exp Neurol 64: 754-762.
48. Muller M, Carter SL, Hofer MJ, Manders P, Getts DR, Getts MT, Dreykluft A, Lu B, Gerard C, King NJ, Campbell IL. 2007. CXCR3 signaling reduces the severity of experimental autoimmune encephalomyelitis by controlling the parenchymal distribution of effector and regulatory T cells in the central nervous system. J Immunol 179: 2774-2786.
49. Nelson TE, Gruol DL. 2004. The chemokine CXCL10 modulates excitatory activity and intracellular calcium signaling in cultured hippocampal neurons. J Neuroimmunol 156: 74-87.
50. Neville LF, Mathiak G, Bagasra O. 1997. The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): A novel, pleiotropic member of the C-X-C chemokine superfamily. Cytokine Growth Factor Rev 8: 207-219.
51. Oh JW, Schwiebert LM, Benveniste EN. 1999. Cytokine regulation of CC, CXC chemokine expression by human astrocytes. J Neurovirol 5: 82-94.
52. Omari KM, John GR, Sealfon SC, Raine CS. 2005. CXC chemokine receptors on human oligodendrocytes: Implications for multiple sclerosis. Brain 128: 1003-1015.
53. Pozzo Miller LD, Mahanty NK, Connor JA, Landis DM. 1994. Spontaneous pyramidal cell death in organotypic slice cultures from rat hippocampus is prevented by glutamate receptor antagonists. Neuroscience 63: 471-487.
54. Ramakers C, Ruijter JM, Deprez RH, Moorman AF. 2003. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci Lett 339: 62-66.
55. Ransohoff RM, Hamilton TA, Tani M, Stoler MH, Shick HE, Major JA, Estes ML, Thomas DM, Tuohy VK. 1993. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J 7: 592-600.
56. Rappert A, Biber K, Nolte C, Lipp M, Schubel A, Lu B, Gerard NP, Gerard C, Boddeke HW, Kettenmann H. 2002. Secondary lymphoid tissue chemokine (CCL21) activates CXCR3 to trigger a Cl- current and chemotaxis in murine microglia. J Immunol 168: 3221-3226.
57. Rappert A, Bechmann I, Pivneva T, Mahlo J, Biber K, Nolte C, Kovac AD, Gerard C, Boddeke HW, Nitsch R, Kettenmann H. 2004. CXCR3-dependent microglial recruitment is essential for dendrite loss after brain lesion. J Neurosci 24: 8500-8509.
58. Salmaggi A, Gelati M, Dufour A, Corsini E, Pagano S, Baccalini R, Ferrero E, Scabini S, Silei V, Ciusani E, De RM. 2002. Expression and modulation of IFN-gamma-inducible chemokines (IP-10, Mig, and I-TAC) in human brain endothelium and astrocytes: Possible relevance for the immune invasion of the central nervous system and the pathogenesis of multiple sclerosis. J Interferon Cytokine Res 22: 631-640.
59. Sanders VJ, Pittman CA, White MG, Wang G, Wiley CA, Achim CL. 1998. Chemokines and receptors in HIV encephalitis. AIDS 12: 1021-1026.
60. Simpson JE, Newcombe J, Cuzner ML, Woodroofe MN. 2000. Expression of the interferon-gamma-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions. Neuropathol Appl Neurobiol 26: 133-142.
61. Sorensen TL, Tani M, Jensen J, Pierce V, Lucchinetti C, Folcik VA, Qin S, Rottman J, Sellebjerg F, Strieter RM, Frederiksen JL, Ransohoff RM. 1999. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest 103: 807-815.
62. Stoppini L, Buchs PA, Muller D. 1991. A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 37: 173-182.
63. Tanuma N, Sakuma H, Sasaki A, Matsumoto Y. 2006. Chemokine expression by astrocytes plays a role in microglia/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis. Acta Neuropathol 112: 195-204.
64. Tikka TM, Koistinaho JE. 2001. Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia. J Immunol 166: 7527-7533.
65. Turrin NP, Rivest S. 2006. Tumor necrosis factor alpha but not interleukin 1 beta mediates neuroprotection in response to acute nitric oxide excitotoxicity. J Neurosci 26: 143-151.
66. Van Rooijen N, Sanders A. 1994. Liposome mediated depletion of macrophages: Mechanism of action, preparation of liposomes and applications. J Immunol Methods 174: 83-93.
67. Vlkolinsky R, Siggins GR, Campbell IL, Krucker T. 2004. Acute exposure to CXC chemokine ligand 10, but not its chronic astroglial production, alters synaptic plasticity in mouse hippocampal slices. J Neuroimmunol 150: 37-47.
68. Vornov JJ, Tasker RC, Coyle JT. 1991. Direct observation of the agonist-specific regional vulnerability to glutamate, NMDA, and kainate neurotoxicity in organotypic hippocampal cultures Exp Neurol 114: 11-22.
69. Wang X, Ellison JA, Siren AL, Lysko PG, Yue TL, Barone FC, Shatzman A, Feuerstein GZ. 1998. Prolonged expression of interferon-inducible protein-10 in ischemic cortex after permanent occlusion of the middle cerebral artery in rat. J Neurochem 71: 1194-1204.
70. Xapelli S, Bernardino L, Ferreira R, Grade S, Silva AP, Salgado JR, Cavadas C, Grouzmann E, Poulsen FR, Jakobsen B, Oliveira CR, Zimmer J, Malva JO. 2008. Interaction between neuropeptide Y (NPY) and brain-derived neurotrophic factor in NPY-mediated neuroprotection against excitotoxicity: A role for microglia. Eur J Neurosci 27: 2089-2102.
71. Xia MQ, Bacskai BJ, Knowles RB, Qin SX, Hyman BT. 2000. Expression of the chemokine receptor CXCR3 on neurons and the elevated expression of its ligand IP-10 in reactive astrocytes: In vitro ERK1/2 activation and role in Alzheimer's disease. J Neuroimmunol 108: 227-235.
72. Yrjanheikki J, Keinanen R, Pellikka M, Hokfelt T, Koistinaho J. 1998. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci USA 95: 15769-15774.